Lifecare ASA

Report Publication Announcement • Aug 22, 2024

Lifecare ASA Q2 2024 presentation

Lifecare ASA Q2 2024 presentation

Lifecare ASA will release its second quarter 2024 results on Tuesday 27 august

2024 at 07:00 a.m. CEST.

The same day at 12:00 CEST, CEO Joacim Holter will present the results live at

Carnegie AS, Fjordalleen 16, Aker Brygge in Oslo.

After the presentation, Lifecare invites to 1:1 session with the CEO and the

CFO.

Link to assess the live webcast and register for presentation and 1:1

meetings: ENROLL

(https://edge-iqy.carnegie.se/Events/Index?parm2=erKtL1HSUQo4+P+rQnACuAvbWnIaYSsrDJtV2aUs/NDzQv+X6DP+Nqmh8NUn8GknSbJoPbdNOQbHCfn91MrxIxp3e4YINWulEkye+KW1VCg=)

About us

Lifecare ASA is a clinical stage medical sensor company developing technology

for sensing and monitoring of various body analytes. Lifecare's main focus is

to bring the next generation of Continuous Glucose Monitoring ("CGM") systems

to market. Lifecare enables osmotic pressure as sensing principle, combined

with the ability to manipulate Nano-granular Tunnelling Resistive sensors

("NTR") on the sensor body for read-out of pressure variations. Lifecare's

sensor technology is referred to as "Sencell" and is suitable for identifying

and monitoring the occurrence of a wide range of analytes and molecules in the

human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42